Align Technology (ALGN) Financials: History & Chart

Align Technology, Inc. (ALGN)ALGNAlign Technology, Inc.

About Align Technology, Inc.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Tempe, AZ

20,290 employees

www.aligntech.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joseph Hogan

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	4.10B	1.04B	1.05B	995.69M	1.01B	979.26M	995.22M	977.87M	1.03B
Cost of Goods Sold	1.32B	303.50M	359.42M	356.49M	304.33M	299.15M	298.28M	296.10M	305.86M
Gross Profit	2.77B	736.59M	688.15M	639.20M	708.12M	680.11M	696.94M	681.77M	722.63M
Gross Profit Margin	67.7%	70.8%	65.7%	64.2%	69.9%	69.5%	70.0%	69.7%	70.3%
Total Operating Expenses	2.18B	564.00M	528.55M	542.90M	545.08M	549.01M	552.79M	519.48M	575.58M
Research & Development	371.37M	98.66M	83.04M	93.28M	96.40M	97.20M	94.88M	85.27M	92.19M
Selling, General & Administrative	1.77B	465.34M	440.74M	417.80M	448.69M	447.63M	424.97M	434.14M	452.26M
Operating Income (EBIT)	591.59M	172.67M	159.59M	96.30M	163.03M	131.10M	144.15M	162.30M	147.05M
Operating Margin	14.4%	16.6%	15.2%	9.7%	16.1%	13.4%	14.5%	16.6%	14.3%
Income Before Tax (EBT)	593.73M	148.89M	176.59M	94.73M	173.52M	140.44M	140.78M	165.93M	143.87M
Interest Income	14.64M	3.91M	4.62M	3.25M	2.86M	5.32M	8.52M	4.00M	3.30M
Interest Expense	1.56M	N/A	N/A	1.56M	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	2.14M	-23.78M	17.00M	-1.56M	10.48M	9.34M	-3.37M	3.63M	-3.18M
Net Income	429.89M	112.77M	135.76M	56.75M	124.61M	93.23M	103.81M	115.96M	96.56M
Income Tax Expense	163.84M	36.12M	40.84M	37.98M	48.91M	47.21M	36.97M	49.97M	47.30M
Net Profit Margin	10.5%	10.8%	13.0%	5.7%	12.3%	9.5%	10.4%	11.9%	9.4%
EBITDA	846.41M	229.22M	261.57M	152.01M	203.61M	170.25M	182.28M	200.09M	183.21M
EBITDA Margin	20.7%	22.0%	25.0%	15.3%	20.1%	17.4%	18.3%	20.5%	17.8%
Depreciation & Amortization	254.82M	56.55M	101.98M	55.72M	40.58M	39.15M	38.13M	37.79M	36.17M
EPS Basic	5.97	1.58	1.89	0.78	1.72	1.27	1.39	1.55	1.28
EPS Diluted	5.96	1.57	1.89	0.78	1.72	1.27	1.39	1.55	1.28
Shares Outstanding	71.42M	71.42M	71.68M	72.38M	72.56M	73.56M	74.42M	74.74M	75.18M
Diluted Shares Outstanding	71.61M	71.61M	71.76M	72.42M	72.59M	73.61M	74.47M	74.76M	75.22M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	4.03B	4.00B	3.86B	3.73B	3.95B	2.47B	2.41B	1.97B
Cost of Goods Sold	1.28B	1.20B	1.16B	1.10B	1.02B	708.71M	662.90M	518.63M
Gross Profit	2.76B	2.80B	2.71B	2.63B	2.94B	1.76B	1.74B	1.45B
Gross Profit Margin	68.3%	70.0%	70.1%	70.5%	74.3%	71.3%	72.5%	73.6%
Total Operating Expenses	2.14B	2.19B	2.06B	1.99B	1.96B	1.38B	1.20B	981.30M
Research & Development	369.91M	364.20M	346.83M	305.26M	250.31M	175.31M	157.36M	128.90M
Selling, General & Administrative	1.76B	1.76B	1.70B	1.67B	1.71B	1.20B	1.07B	852.40M
Operating Income (EBIT)	616.22M	607.63M	643.34M	642.60M	976.40M	387.17M	542.49M	466.56M
Operating Margin	15.3%	15.2%	16.7%	17.2%	24.7%	15.7%	22.5%	23.7%
Income Before Tax (EBT)	585.29M	608.96M	641.20M	599.06M	1.01B	378.95M	555.12M	457.96M
Interest Income	16.05M	20.22M	17.26M	5.37M	3.10M	3.13M	12.48M	8.58M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	-30.93M	1.33M	-2.13M	-43.54M	36.02M	-8.22M	12.63M	-8.61M
Net Income	410.35M	421.36M	445.05M	361.57M	772.02M	1.78B	442.78M	400.24M
Income Tax Expense	174.94M	187.60M	196.15M	237.48M	240.40M	-1.40B	112.35M	57.72M
Net Profit Margin	10.2%	10.5%	11.5%	9.7%	19.5%	71.8%	18.4%	20.4%
EBITDA	796.80M	752.66M	785.74M	768.39M	1.09B	480.71M	621.48M	521.29M
EBITDA Margin	19.7%	18.8%	20.3%	20.6%	27.5%	19.4%	25.8%	26.5%
Depreciation & Amortization	180.59M	145.03M	142.40M	125.79M	108.73M	93.54M	78.99M	54.73M
EPS Basic	5.66	5.63	5.82	4.62	9.78	22.55	5.57	5.00
EPS Diluted	5.65	5.62	5.81	4.61	9.69	22.41	5.53	4.92
Shares Outstanding	72.54M	74.88M	76.43M	78.19M	78.92M	78.76M	79.42M	80.06M
Diluted Shares Outstanding	72.59M	74.99M	76.57M	78.42M	79.67M	79.23M	80.10M	81.36M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.